In-depth Inference of Transcriptional Regulatory Networks Reveals NPM1 As a Therapeutic Ribosomal Regulator in MYC-amplified Medulloblastoma

Overview

Journal NPJ Precis Oncol

Publisher Springer Nature

Date 2025 Jan 10

PMID 39794402

Authors

Tong Chen

Huiyao Chen

Mingyang Xia

Yunfei Liao

Hao Li

Xinran Dong

Yifeng Lin

Wenhao Zhou

Affiliations

Soon will be listed here.

Abstract

Medulloblastoma (MB) is an aggressive pediatric brain tumor with distinct molecular heterogeneity. Identifying subtype-specific signatures within Group 3 and Group 4 remains challenging due to shared cytogenetic alterations and limitations of conventional differential gene expression analysis. To uncover the underlying molecular signatures and hidden regulators, we used the Cavalli transcriptomic profile of 470 Group 3 and Group 4 MB patients to reconstruct subtype-specific regulatory networks. A strong upregulation of the ribosomal pathway was linked to MYC amplification in Group 3, with Nucleophosmin 1 (NPM1) emerging as a key regulator. NPM1 upregulation defined a subset of Group3 and Group4 patients with poor prognosis. Inhibition of NPM1 led to apoptosis, reduced c-Myc stability, and impaired translation in MYC-amplified Group 3 MB cells. Together, our findings highlight NPM1 as a promising therapeutic target and provide new insights into the regulatory mechanisms in MB.

References

Smith K, Bihannic L, Gudenas B, Haldipur P, Tao R, Gao Q . Unified rhombic lip origins of group 3 and group 4 medulloblastoma. Nature. 2022; 609(7929):1012-1020. PMC: 9748853. DOI: 10.1038/s41586-022-05208-9. View

Simovic M, Bolkestein M, Moustafa M, Wong J, Korber V, Benedetto S . Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model. Neuro Oncol. 2021; 23(12):2028-2041. PMC: 8643436. DOI: 10.1093/neuonc/noab127. View

Carter R, Bihannic L, Rosencrance C, Hadley J, Tong Y, Phoenix T . A Single-Cell Transcriptional Atlas of the Developing Murine Cerebellum. Curr Biol. 2018; 28(18):2910-2920.e2. DOI: 10.1016/j.cub.2018.07.062. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Northcott P, Buchhalter I, Morrissy A, Hovestadt V, Weischenfeldt J, Ehrenberger T . The whole-genome landscape of medulloblastoma subtypes. Nature. 2017; 547(7663):311-317. PMC: 5905700. DOI: 10.1038/nature22973. View

Devaiah B, Mu J, Akman B, Uppal S, Weissman J, Cheng D . MYC protein stability is negatively regulated by BRD4. Proc Natl Acad Sci U S A. 2020; 117(24):13457-13467. PMC: 7306749. DOI: 10.1073/pnas.1919507117. View

Hovestadt V, Ayrault O, Swartling F, Robinson G, Pfister S, Northcott P . Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer. 2019; 20(1):42-56. PMC: 9113832. DOI: 10.1038/s41568-019-0223-8. View

Weishaupt H, Johansson P, Sundstrom A, Lubovac-Pilav Z, Olsson B, Nelander S . Batch-normalization of cerebellar and medulloblastoma gene expression datasets utilizing empirically defined negative control genes. Bioinformatics. 2019; 35(18):3357-3364. PMC: 6748729. DOI: 10.1093/bioinformatics/btz066. View

Basso K, Margolin A, Stolovitzky G, Klein U, Dalla-Favera R, Califano A . Reverse engineering of regulatory networks in human B cells. Nat Genet. 2005; 37(4):382-90. DOI: 10.1038/ng1532. View

10.

Wang W, Liao P, Shen M, Chen T, Chen Y, Li Y . SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62. Oncogene. 2015; 35(4):491-500. DOI: 10.1038/onc.2015.106. View

11.

Ferrucci V, De Antonellis P, Pennino F, Asadzadeh F, Virgilio A, Montanaro D . Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition. Brain. 2018; 141(5):1300-1319. DOI: 10.1093/brain/awy039. View

12.

Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View

13.

Cela I, Di Matteo A, Federici L . Nucleophosmin in Its Interaction with Ligands. Int J Mol Sci. 2020; 21(14). PMC: 7402337. DOI: 10.3390/ijms21144885. View

14.

Pecoraro A, Pagano M, Russo G, Russo A . Ribosome Biogenesis and Cancer: Overview on Ribosomal Proteins. Int J Mol Sci. 2021; 22(11). PMC: 8197113. DOI: 10.3390/ijms22115496. View

15.

Brown I, Lafita-Navarro M, Conacci-Sorrell M . Regulation of Nucleolar Activity by MYC. Cells. 2022; 11(3). PMC: 8834138. DOI: 10.3390/cells11030574. View

16.

Forget A, Martignetti L, Puget S, Calzone L, Brabetz S, Picard D . Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling. Cancer Cell. 2018; 34(3):379-395.e7. DOI: 10.1016/j.ccell.2018.08.002. View

17.

Ramaswamy V, Taylor M . Medulloblastoma: From Myth to Molecular. J Clin Oncol. 2017; 35(21):2355-2363. DOI: 10.1200/JCO.2017.72.7842. View

18.

Li Z, Hann S . Nucleophosmin is essential for c-Myc nucleolar localization and c-Myc-mediated rDNA transcription. Oncogene. 2012; 32(15):1988-94. PMC: 3855075. DOI: 10.1038/onc.2012.227. View

19.

Cavalli F, Remke M, Rampasek L, Peacock J, Shih D, Luu B . Intertumoral Heterogeneity within Medulloblastoma Subgroups. Cancer Cell. 2017; 31(6):737-754.e6. PMC: 6163053. DOI: 10.1016/j.ccell.2017.05.005. View

20.

Khouri-Farah N, Guo Q, Morgan K, Shin J, Li J . Integrated single-cell transcriptomic and epigenetic study of cell state transition and lineage commitment in embryonic mouse cerebellum. Sci Adv. 2022; 8(13):eabl9156. PMC: 10938588. DOI: 10.1126/sciadv.abl9156. View